Managing your inbox is a never-ending task, which is why we should seek to simplify it as much as possible. When emails pile up, you start overthinking what you need to do—I know I do, anyway. But if ...
If you've invested in one of the best OLED TVs or best projectors, you'd be doing yourself (and your new purchase) a disservice if you're not pairing it with an equally cinematic sound system.
The washed-up platforming mascot is back. Again. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on Google Polite ...
Let’s get one thing out of the way: I hate Bubsy. Not Bubsy 4D, the interesting, vibrant game I’m actually previewing here, but rather Bubsy himself, the mangy, atrocious feline, a poisonous product ...
Maxon has announced the Fall 2025 release of Maxon One, the company’s unified creative ecosystem that includes Cinema 4D, ZBrush, Redshift, Red Giant, and Maxon Studio. The latest Maxon One update ...
Sentronics has launched its new RealFlow d450 and d600 series at the Defence and Security Equipment (DSEI) event taking place this week at Excel, London. Image courtesy ADS The revolutionary new micro ...
On the first day of the Hungry Ghost Month last Saturday (Aug 23), a group of devotees in Sembawang struck it big after betting on a 'lucky' 4D number posted at the prayer altar. The 'lucky' number ...
Publisher Atari and developer Fabraz have announced Bubsy 4D for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC (Steam, Epic Games Store, GOG). A release date was not ...
Bubsy the Bobcat, star of the eponymous, oft-derided Bubsy series of hit-or-miss platforming games, is back in a new adventure called Bubsy 4D. Publisher Atari and developer Fabraz, known for the ...
4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. The ...
4D Molecular Therapeutics laid off a quarter of its workforce last month with early-stage R&D bearing the brunt of the changes. The genetic medicines biotech said shrinking its headcount by 25% should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback